CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-29 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +23,250 | 23,250 | ||
| 2023-03-29 | Sellig Thomas Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2023-03-29 | KING THOMAS BRAXTON Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2023-03-29 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2023-01-25 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +15,000 | 15,000 | ||
| 2023-01-25 | Wan Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-01-25 | Stewart Richard Alistair Executive Chairman | Grant or award · Performance Restricted Stock Unit (PRSU) | +75,000 | 75,000 | ||
| 2023-01-25 | Stewart Richard Alistair Executive Chairman | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2023-01-25 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +60,000 | 60,000 | ||
| 2023-01-25 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-01-25 | Bencich John CEO | Grant or award · Performance Restricted Stock Unit (PRSU) | +100,000 | 100,000 | ||
| 2023-01-25 | Bencich John CEO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-11-18 | Bencich John CEO | Purchase | +22,000 | 36,920 | ||
| 2022-11-18 | Bencich John CEO | Purchase · Common Stock Warrants (right to buy) | +11,000 | 11,000 | ||
| 2022-11-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-11-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-11-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-10-03 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-10-03 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-10-03 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 |
Page 8 of 36 · 715 trades